Human KRAS/NRAS/BRAF/PIK3CA Gene Mutation Test Kit

Genecast CRC is the first NGS companion diagnostic kit especially for colorectal cancer approved by national medical products administration (NMPA) in China. The kit detects somatic variants across 29 genes and microsatellite instability (MSI) status, enabling accurate and rapid matching of patients to relevant targeted therapy and immunotherapy regimens.

Key Features and Benefits

• Comprehensive Coverage

  Targets NCCN guideline-recommended genes with direct therapeutic implications

• Accurate Data

  >99% consistency with gold standard in clinical samples

• High Sensitivity

  Detects key cancer driver gene mutations (KRAS/NRAS/BRAF/PIK3CA) with a LOD as low as 1%

Companion Diagnostic Biomarker and Therapy Approved by NMPA

The gene list of Human KRAS/NRAS/BRAF/PIK3CA Gene Mutation Test kit

Specifications